Navigation Links
TPI Operation Undisturbed by the Sichuan Earthquake

CHENGDU, China, May 1, 2013 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) today reported that TPI's operation sustained the recent  earthquake and the following aftershocks caused by the Ya'an earthquake in Sichuan province on April 20th, 2013. Manufacturing facilities of TPI at Longquan County and Xinjin County of Chengdu have been operating undisturbed during the earthquake and the aftershocks that followed.

Ya'an earthquake

The Ya'an earthquake occurred at 8:02AM Beijing Time on April 20, 2013 with the epicenter located in Lushan County, Ya'an City, Sichuan, about 72 miles from the capital of Sichuan province, Chengdu. The magnitude of the earthquake was measured at a range of 6.6 to 7.0 by China Earthquake Data Center with 1,815 aftershocks have been recorded within the first 72 hours. The earthquake has resulted in 196 people dead, 24 missing, and at least 11,826 injured with more than 968 seriously injured (

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, mTCM, branded generics and API. TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI's pipeline targets various high incidence healthcare indications. For more information about TPI, please visit:

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please visit:, or email     

Tel: +86-28-8551-6696 (Chengdu, China)
      +86-134-3655-0011 (China)

Tianyin Pharmaceutical
23rd Floor, Unionsun Yangkuo Plaza     
No. 2, Block 3, South Renmin Road
Chengdu, 610041

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Deborah Autor, FDAs Deputy Commissioner for Global Regulatory Operations and Policy, to Join Mylan
2. Cannabis Science announces preclinical development program for CS-TATI-I, commencing EU operations in the Netherlands and sourcing proprietary material for pharmacokinetic characterization
3. The Council on Alcohol and Drugs and Georgia Law Enforcement Launch Statewide "Operation Drug Drop Off" Campaign
4. Quest Diagnostics to Acquire Lab-Related Clinical Outreach Operations of Dignity Health in California and Nevada
5. Hospira Names Matthew R. Stober Senior Vice President of Operations
6. Epsen Fuller Group Recruits Operations Leader for Global Biotech Firm SOTIO
7. Rotech Receives Approval of First Day Motions; Approvals Ensure Operations Continue Normally
8. Nick Pace Named EVP -- Operations, Compliance, and Regulatory
9. Pre-Sutured Tendon From LifeNet Health Increases Surgeon Efficiency, Reduces Operation Room Time
10. Psyche Systems Launches New Module for Laboratories to Manage Operational Efficiencies
11. AnazaoHealth Announces Full Continued Cooperation with FDA to Promote Quality Assurance and Patient Safety
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):